178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Recognizing young people's perspectives in inflammatory arthritis

Recognizing young people's perspectives in inflammatory arthritis

by EULARFigure 1 Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.Inflammatory arthritis is the na

Recognizing young people's perspectives in inflammatory arthritis

by EULARFigure 1 Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.Inflammatory arthritis is the na
Declining antibodies and immunity to COVID-19 – why the worry?

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di
COVID-19 model reveals key role for innate immunity in controlling viral load

COVID-19 model reveals key role for innate immunity in controlling viral load

by American Chemical SocietyColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the N

COVID-19 model reveals key role for innate immunity in controlling viral load

by American Chemical SocietyColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the N
Risankizumab safe, effective at 52 weeks for psoriatic arthritis

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe
A year of COVID-19 lockdown is putting kids at risk of allergies, asthma and autoimmune diseases

A year of COVID-19 lockdown is putting kids at risk of allergies, asthma and autoimmune diseases

by Byram W. Bridle,The ConversationCredit: Unsplash/CC0 Public Domain"Eat dirt!" is a phrase I remember well. It was in thetitle of an articlepublished by Harvard Universit

A year of COVID-19 lockdown is putting kids at risk of allergies, asthma and autoimmune diseases

by Byram W. Bridle,The ConversationCredit: Unsplash/CC0 Public Domain"Eat dirt!" is a phrase I remember well. It was in thetitle of an articlepublished by Harvard Universit
Study finds holding methotrexate for one week after flu vaccine may be as effective as a two-week hold

Study finds holding methotrexate for one week after flu vaccine may be as effective as a two-week hold

by American College of RheumatologyStudy design and vaccine response at 4 and 16 weeks. (A) Study design. (B) The percentage of patients achieving a satisfactory vaccine response, defined as ≥4-f

Study finds holding methotrexate for one week after flu vaccine may be as effective as a two-week hold

by American College of RheumatologyStudy design and vaccine response at 4 and 16 weeks. (A) Study design. (B) The percentage of patients achieving a satisfactory vaccine response, defined as ≥4-f
FDA approves first interchangeable biosimilar for inflammatory diseases

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),
Chemical stimuli can support growing of stable cartilage cells

Chemical stimuli can support growing of stable cartilage cells

by Umea UniversityRho-kinase inhibition cause disappearance of cellular adhesion sites. The colors of the figure shows the staining for actin stress fibers (red), adhesion plaques-related vinculi

Chemical stimuli can support growing of stable cartilage cells

by Umea UniversityRho-kinase inhibition cause disappearance of cellular adhesion sites. The colors of the figure shows the staining for actin stress fibers (red), adhesion plaques-related vinculi
Triple contrast method for computed tomography diagnostics of cartilage injuries

Triple contrast method for computed tomography diagnostics of cartilage injuries

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainPost-traumatic osteoarthritis (PTOA) is a joint disease associated with the gradual erosion of cartilage covering the ends of arti

Triple contrast method for computed tomography diagnostics of cartilage injuries

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainPost-traumatic osteoarthritis (PTOA) is a joint disease associated with the gradual erosion of cartilage covering the ends of arti
MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

by Public Library of ScienceProject design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

by Public Library of ScienceProject design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe
Study establishes IL-24 as a critical factor for onset and progression of atopic dermatitis

Study establishes IL-24 as a critical factor for onset and progression of atopic dermatitis

by Higher Education PressIL-24, which is expressed in keratinocytes and induced by S. aureus infection, promotes atopic dermatitis-like inflammation by enhancing a type 2 immune response. Credit: Xinm

Study establishes IL-24 as a critical factor for onset and progression of atopic dermatitis

by Higher Education PressIL-24, which is expressed in keratinocytes and induced by S. aureus infection, promotes atopic dermatitis-like inflammation by enhancing a type 2 immune response. Credit: Xinm
CAR T cells suppress GI solid tumor cells, without toxicity to healthy tissue, in preclinical research

CAR T cells suppress GI solid tumor cells, without toxicity to healthy tissue, in preclinical research

by University of PennsylvaniaCDH17 CARTs attack tumor but spare normal tissue. Credit: Penn MedicineChimeric antigen receptor (CAR) T cells can be remarkably effective in treating leukemias and l

CAR T cells suppress GI solid tumor cells, without toxicity to healthy tissue, in preclinical research

by University of PennsylvaniaCDH17 CARTs attack tumor but spare normal tissue. Credit: Penn MedicineChimeric antigen receptor (CAR) T cells can be remarkably effective in treating leukemias and l